UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pilot trial of high-dose vitamin C in critically ill COVID-19 patients

Annals of intensive care, 2021-01, Vol.11 (1), p.5-5, Article 5

2021

Volltextzugriff (PDF)

Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection

Frontiers in immunology, 2020-02, Vol.10, p.3127-3127

2020

Volltextzugriff (PDF)

Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art

Frontiers in immunology, 2020-11, Vol.11, p.577442-577442

2020

Volltextzugriff (PDF)

The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area

Current topics in medicinal chemistry, 2021, Vol.21 (10), p.920-927

2021

Volltextzugriff (PDF)

Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling

Stem cell research & therapy, 2021-07, Vol.12 (1), p.396-396, Article 396

2021

Volltextzugriff (PDF)

mTOR Signaling: The Interface Linking Cellular Metabolism and Hepatitis B Virus Replication

Virologica Sinica, 2021-12, Vol.36 (6), p.1303-1314

2021

Volltextzugriff (PDF)

Hepatitis B Virus Suppresses Toll-like Receptor-Mediated Innate Immune Responses in Murine Parenchymal and Nonparenchymal Liver Cells

Hepatology (Baltimore, Md.), 2009-04, Vol.49 (4), p.1132-1140

2009

Volltextzugriff (PDF)

RNA Interference-Induced Innate Immunity, Off-Target Effect, or Immune Adjuvant?

Frontiers in immunology, 2017-03, Vol.8, p.331-331

2017

Volltextzugriff (PDF)

Editorial: Targeting the Immune System to Treat Hepatitis B Virus Infection

Frontiers in immunology, 2022-03, Vol.13, p.868616-868616

2022

Volltextzugriff (PDF)

ANGPTL8 accelerates liver fibrosis mediated by HFD-induced inflammatory activity via LILRB2/ERK signaling pathways

Journal of advanced research, 2023-05, Vol.47, p.41-56

2023

Volltextzugriff (PDF)

Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific

Immunology, 2010-03, Vol.129 (3), p.363-374

2010

Volltextzugriff (PDF)

Toll‐like receptor‐mediated control of HBV replication by nonparenchymal liver cells in mice

Hepatology (Baltimore, Md.), 2007-12, Vol.46 (6), p.1769-1778

2007

Volltextzugriff (PDF)

MHBSt167 induced autophagy promote cell proliferation and EMT by activating the immune response in L02 cells

Virology journal, 2022-06, Vol.19 (1), p.1-110, Article 110

2022

Volltextzugriff (PDF)

Cohort profile: a multicentre prospective validation cohort of the Chinese Acute-on-Chronic Liver Failure (CATCH-LIFE) study

BMJ open, 2021-01, Vol.11 (1), p.e037793-e037793

2021

Volltextzugriff (PDF)

Role of Toll-like receptor 2 in the immune response against hepadnaviral infection

Journal of hepatology, 2012-09, Vol.57 (3), p.522-528

2012

Volltextzugriff (PDF)

Correction to: Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling

Stem cell research & therapy, 2022-02, Vol.13 (1), p.65-65, Article 65

2022

Volltextzugriff (PDF)

Severe anemia is associated with increased short-term and long-term mortality in patients hospitalized with cirrhosis

Annals of hepatology, 2023-11, Vol.28 (6), p.101147, Article 101147

2023

Volltextzugriff (PDF)

CANPT Score: A Tool to Predict Severe COVID-19 on Admission

Frontiers in medicine, 2021-02, Vol.8, p.608107-608107

2021

Volltextzugriff (PDF)

Culture-Positive Spontaneous Ascitic Infection in Patients with Acute Decompensated Cirrhosis: Multidrug-Resistant Pathogens and Antibiotic Strategies

Yonsei Medical Journal, 2020, 61(2), , pp.145-153

2020

Volltextzugriff (PDF)

Dual role of ANGPTL8 in promoting tumor cell proliferation and immune escape during hepatocarcinogenesis

Oncogenesis (New York, NY), 2023-05, Vol.12 (1), p.26-26, Article 26

2023

Volltextzugriff (PDF)

Immunostimulatory siRNA with a uridine bulge leads to potent inhibition of HBV and activation of innate immunity

Virology journal, 2021-02, Vol.18 (1), p.37-37, Article 37

2021

Volltextzugriff (PDF)

Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication

Journal of hepatology, 2008-06, Vol.48 (6), p.914-922

2008

Volltextzugriff (PDF)

Hepatitis B Virus Reactivation Increased the Risk of Developing Hepatic Failure and Mortality in Cirrhosis With Acute Exacerbation

Frontiers in microbiology, 2022-07, Vol.13, p.910549-910549

2022

Volltextzugriff (PDF)

Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China

BMJ open, 2024-07, Vol.14 (7), p.e081623

2024

Volltextzugriff (PDF)

High Dose Intravenous Vitamin C as Adjunctive Therapy for COVID-19 Patients with Cancer: Two Cases

Life (Basel, Switzerland), 2022-02, Vol.12 (3), p.335

2022

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Englisch
(87)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Pilot trial of high-dose vitamin C in critically ill COVID-19 patients

Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection

Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art

The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area

Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling

mTOR Signaling: The Interface Linking Cellular Metabolism and Hepatitis B Virus Replication

Hepatitis B Virus Suppresses Toll-like Receptor-Mediated Innate Immune Responses in Murine Parenchymal and Nonparenchymal Liver Cells

RNA Interference-Induced Innate Immunity, Off-Target Effect, or Immune Adjuvant?

Editorial: Targeting the Immune System to Treat Hepatitis B Virus Infection

ANGPTL8 accelerates liver fibrosis mediated by HFD-induced inflammatory activity via LILRB2/ERK signaling pathways

Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific

Toll‐like receptor‐mediated control of HBV replication by nonparenchymal liver cells in mice

MHBSt167 induced autophagy promote cell proliferation and EMT by activating the immune response in L02 cells

Cohort profile: a multicentre prospective validation cohort of the Chinese Acute-on-Chronic Liver Failure (CATCH-LIFE) study

Role of Toll-like receptor 2 in the immune response against hepadnaviral infection

Correction to: Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling

Severe anemia is associated with increased short-term and long-term mortality in patients hospitalized with cirrhosis

CANPT Score: A Tool to Predict Severe COVID-19 on Admission

Culture-Positive Spontaneous Ascitic Infection in Patients with Acute Decompensated Cirrhosis: Multidrug-Resistant Pathogens and Antibiotic Strategies

Dual role of ANGPTL8 in promoting tumor cell proliferation and immune escape during hepatocarcinogenesis

Immunostimulatory siRNA with a uridine bulge leads to potent inhibition of HBV and activation of innate immunity

Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication

Hepatitis B Virus Reactivation Increased the Risk of Developing Hepatic Failure and Mortality in Cirrhosis With Acute Exacerbation

Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China

High Dose Intravenous Vitamin C as Adjunctive Therapy for COVID-19 Patients with Cancer: Two Cases

Suchergebnisse filtern